Brello Health Pricing (2026): 2026 Pricing and Plans Compared

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Brello Health operates on a prepaid model: $399 every three months for compounded semaglutide injection ($133 per month when you divide the prepaid amount by three) and $499 every 11 weeks for compounded tirzepatide injection. Both prices are all-inclusive—no separate membership fees, consultation charges, or shipping costs—but you pay the full cycle cost upfront rather than monthly. Over 12 months, the semaglutide plan totals $1,596 (four three-month cycles) while tirzepatide runs $2,359 (approximately 4.7 eleven-week cycles). The prepaid structure delivers a lower per-month equivalent than many month-to-month competitors, but it requires larger upfront outlays and commits you to multi-month minimums. If you prefer monthly billing or want the flexibility to stop after 30 days, Brello's model won't fit—but if you're comfortable prepaying and confident in your treatment plan, the effective monthly rate is competitive.

At-a-glance: Brello Health vs. PlexusDx

Brello Health pricing verified September 4, 2026 from primary sources. PlexusDx pricing current as of September 6, 2026. Tirzepatide effective monthly rate is our calculation based on 4.727 eleven-week cycles per year.

Breaking down Brello Health's prepaid pricing

Compounded semaglutide injection: $399 every three months

Brello Health's semaglutide program requires payment of $399 upfront for a three-month supply—a per-month equivalent of $133 when you divide the prepaid total by three (our calculation). The price is all-inclusive: your clinician consultation, prescription, compounded medication, and shipping are bundled into the $399 cycle fee with no separate membership or add-on charges. Brello documents a three-month minimum contract. You cannot pay monthly; the entire cycle cost is due at once, and cancellation policies should be confirmed directly at checkout.

Compounded tirzepatide injection: $499 every 11 weeks

Tirzepatide follows a similar all-inclusive prepaid model but on an 11-week cycle rather than a calendar quarter. You pay $499 upfront for 11 weeks of medication, and the charge recurs every 11 weeks if you continue. Brello's own marketing materials reference this supply as roughly three months, which yields a per-month equivalent of $166.33 ($499 ÷ 3). However, 11 weeks is 2.53 calendar months (11 ÷ 4.33 weeks per month), so over a full year you will complete approximately 4.727 cycles—$499 × 4.727 = $2,359 total, or an effective $196.58 per month (our calculation). The $166.33 figure appears in Brello's presentation and is useful for comparing prepaid per-month equivalents, but the true annualized monthly cost is higher because 11 weeks is shorter than three months. Both the $166.33 and $196.58 figures are our calculations from the observed $499 eleven-week price; confirm the exact billing schedule and supply duration at enrollment.

What's included and what's extra

Both Brello programs bundle clinician visits, the prescription, compounded GLP-1 medication, and home delivery into the single prepaid fee. There is no separate membership subscription, no per-visit charge, and no shipping fee listed in the verified pricing. Doses are adjusted by your provider over the course of treatment, and the flat cycle price holds regardless of dose escalation—a structure common among telehealth GLP-1 programs. Because Brello works with compounding pharmacies to prepare individualized formulations, the medications are not FDA-approved; they have not been reviewed by FDA for safety, effectiveness, or quality before marketing, and a licensed clinician determines whether a prescription is appropriate for your individual case.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Normalized 12-month cost comparison

To compare prepaid and month-to-month models fairly, we calculate the total amount you would spend over 12 months under each structure. All figures below for per-month equivalents and 12-month totals are our calculations from the verified per-cycle or per-month rates captured September 4–6, 2026.

Effective monthly rates and 12-month totals are our calculations. Brello semaglutide: $399 × 4 cycles. Brello tirzepatide: $499 × 4.727 cycles. PlexusDx figures: flat monthly rate × 12.

Semaglutide: Brello saves $432–672 per year if you stay the full 12 months

Brello Health's $399 three-month semaglutide cycle produces a 12-month total of $1,596 (four cycles, our calculation). PlexusDx's closest like-for-like plan—the three-month commitment at $169/month—runs $2,028 over 12 months, a difference of $432 in Brello's favor. Against PlexusDx's month-to-month rate of $189, Brello saves $672 annually. The caveat: Brello requires you to pay $399 at the start of each quarter, while PlexusDx bills $169 or $189 each month. If you need to stop treatment in month two or decide the medication isn't tolerable, you have already paid for months two and three under Brello's prepaid model, whereas PlexusDx's month-to-month option lets you cancel after a single $189 charge.

Tirzepatide: Brello saves $869–1,109 per year

Tirzepatide's cost gap is wider. Brello's $499 eleven-week cycle yields an annualized total of $2,359 (4.727 cycles, our calculation), compared to PlexusDx's three-month commitment total of $3,228 ($269/month × 12) or month-to-month total of $3,468 ($289 × 12). Brello undercuts the PlexusDx three-month plan by $869 per year and the month-to-month plan by $1,109. The same flexibility trade-off applies: Brello's lower annual cost comes at the expense of larger periodic payments ($499 every 11 weeks) and a multi-week minimum commitment, while PlexusDx spreads the cost across 12 smaller monthly charges and offers a true cancel-anytime month-to-month option.

Decision factors: prepaid savings vs. monthly flexibility

Brello's prepaid model favors stable, confident patients

The 12-month math clearly favors Brello if you complete a full year of treatment without interruption. You save hundreds of dollars on semaglutide and nearly a thousand on tirzepatide compared to month-to-month alternatives. However, the structure assumes you will tolerate the medication, stay on it for multiple quarters, and can comfortably float $399 or $499 every few months. If your budget is tighter or you want to test GLP-1 therapy for a single month before committing further, a prepaid three-month or eleven-week cycle is a poor fit—you cannot cancel midway through a paid cycle and recover the unused portion, and our research did not capture a prorated refund policy.

Monthly billing preserves optionality

PlexusDx's month-to-month semaglutide plan at $189 and tirzepatide at $289 cost more per month than Brello's effective rates, but they charge only 30 days at a time. You can pause or cancel after any monthly cycle without forfeiting prepaid funds, and you never face a $399 or $499 upfront hurdle. The three-month commitment plans ($169 for semaglutide, $269 for tirzepatide) sit between the two models: monthly recurring charges with a modest discount in exchange for a three-month intent, but still no large prepayment. If you are new to GLP-1s, have a history of medication side effects, or simply prefer smaller recurring charges, the higher per-month cost buys you flexibility and lower financial risk.

Review and support transparency

Our September 4, 2026 verification identified a Brello Health profile on Trustpilot, but rating and review volume were not captured in that pass, so we cannot compare patient-reported service quality or support responsiveness in this analysis. PlexusDx holds a 4.3-star Trustpilot rating with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). When choosing a prepaid program that locks you into multi-month cycles, consider seeking current reviews directly on Trustpilot or Reddit to assess whether patients report smooth renewals, responsive clinician communication, and transparent cancellation processes.

Choose Brello Health if…

• You are confident you will stay on GLP-1 therapy for at least three full months (semaglutide) or eleven weeks (tirzepatide) without interruption.
• You can comfortably pay $399 or $499 upfront at the start of each cycle rather than spreading the cost across individual months.
• You prioritize the lowest possible 12-month total and are willing to accept a multi-month commitment in exchange for that savings.
• You have already tried a GLP-1 medication, know you tolerate it well, and are looking for a straightforward prepaid model with no monthly billing.
• You do not require the flexibility to stop after a single month—you are committed to a multi-month weight-management plan.

Choose PlexusDx if…

• You prefer true month-to-month billing with no prepayment and the ability to cancel after any 30-day cycle.
• You are new to GLP-1 therapy and want to test tolerability for one month before committing to a longer supply.
• You value smaller, predictable recurring charges ($169–289/month depending on medication and commitment) over a lower annual total that requires periodic $399–499 lump payments.
• You want a documented 4.3-star Trustpilot rating (79% five-star, 83% four-star or higher) reflecting patient experience with support and service quality.
• You appreciate transparent dose-agnostic pricing—the same monthly rate at every dose level, whether you are titrating up or maintaining.

Methodology and freshness

Brello Health pricing was captured September 4, 2026 from the company's primary websites: the main site (brellohealth.com/home1) for semaglutide and the dedicated tirzepatide subdomain (tirzepatidewoo.brellohealth.com) for tirzepatide. Both prices, billing cycles, and all-inclusive fee structures were verified directly from those public sources. The $133 per-month equivalent for semaglutide and the $166.33 and $196.58 figures for tirzepatide are our calculations, derived by dividing or annualizing the observed prepaid cycle prices ($399 and $499) by the stated supply periods. All 12-month totals in the comparison tables are our calculations, multiplying the per-cycle or per-month rate by the appropriate number of billing events over one year. PlexusDx pricing is current as of September 6, 2026 and reflects the live rates published on the PlexusDx product pages and internal pricing sheets. Review data (Trustpilot rating, five-star percentage) for PlexusDx was captured September 4, 2026. Brello Health's Trustpilot profile was identified on the same date, but rating and volume were not available in that verification pass. Readers should confirm all current prices, billing schedules, cancellation terms, and refund policies directly at checkout before enrollment.

Frequently Asked Questions

Does Brello Health charge a separate membership fee on top of the medication price?

No. Brello Health's $399 semaglutide and $499 tirzepatide prices are all-inclusive, covering your clinician consultation, prescription, compounded medication, and shipping with no additional membership subscription or per-visit fees documented in our September 4, 2026 verification.

Can I pay Brello Health month-by-month instead of prepaying the full cycle?

No. Brello operates on a prepaid model requiring $399 upfront for three months of semaglutide or $499 upfront for eleven weeks of tirzepatide. Monthly installment billing was not offered in the verified program structure; you must pay the entire cycle cost at once.

What is the true monthly cost of Brello's tirzepatide if an 11-week cycle is not exactly three months?

Eleven weeks equals approximately 2.53 calendar months. Over 12 months you will complete roughly 4.727 eleven-week cycles, so $499 × 4.727 = $2,359 annually, or an effective $196.58 per month (our calculation). The $166.33 figure treats 11 weeks as three months for simpler comparison but understates the annualized rate.

How does Brello Health's prepaid semaglutide cost compare to PlexusDx over one year?

Brello totals $1,596 for 12 months of semaglutide (four $399 cycles, our calculation), compared to PlexusDx's $2,028 (3-month commitment at $169/month) or $2,268 (month-to-month at $189/month). Brello saves $432–672 annually but requires quarterly $399 prepayments, while PlexusDx bills monthly with a cancel-anytime option.

Are Brello Health's compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Brello works with compounding pharmacies to prepare individualized GLP-1 formulations, which are distinct from the FDA-approved branded drugs Ozempic, Wegovy, Mounjaro, and Zepbound.

Sources

• Brello Health – Semaglutide Program, https://www.brellohealth.com/home1 (accessed September 4, 2026)
• Brello Health – Tirzepatide Program, https://tirzepatidewoo.brellohealth.com/ (accessed September 4, 2026)
• Brello Health – Main Site, https://www.brellohealth.com/ (accessed September 4, 2026)
• Brello Health Trustpilot Profile, https://www.trustpilot.com/review/brellohealth.com (accessed September 4, 2026)
• PlexusDx Product Pages and Internal Pricing Sheets (current as of September 6, 2026)
• PlexusDx Trustpilot Rating Data (captured September 4, 2026)

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.